Why Advance Auto Parts (AAP) Shares Are Sliding Today
The announcement has sparked concerns of a renewed trade war, leading to widespread investor anxiety and a sell-off in the broader market. For a retailer like Advance Auto Parts, which sources products through a global supply chain, the prospect of new tariffs is particularly concerning. Tariffs, which are taxes on imported goods, can lead to higher costs for the company. These increased costs could either be absorbed, squeezing profit margins, or passed on to consumers through higher prices, which could potentially dampen demand for its products. The uncertainty surrounding future trade policies is weighing on investor sentiment for companies with significant international supply chains.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Advance Auto Parts? Access our full analysis report here, it's free.
Advance Auto Parts's shares are extremely volatile and have had 32 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
Advance Auto Parts is up 28.4% since the beginning of the year, and at $61.79 per share, it is trading close to its 52-week high of $64.44 from July 2024. Investors who bought $1,000 worth of Advance Auto Parts's shares 5 years ago would now be looking at an investment worth $445.91.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
16 minutes ago
- USA Today
Nvidia stock investors just got great news from the Trump Administration
Nvidia (NASDAQ: NVDA) has been a cornerstone of the artificial intelligence (AI) boom. The stock has advanced 1,070% since January 2023 as the company has reported tremendous financial results, driven by strong demand for its graphics processing units (GPUs) and other data center infrastructure. Nevertheless, export restrictions imposed by the U.S. government have cost the company billions of dollars in sales. Fortunately, Nvidia shareholders recently got great news from the Trump administration: Applications to resume selling its H20 GPUs in China will be approved by the Commerce Department. Here's what investors should know. How semiconductor export restrictions have impacted Nvidia under the Biden and Trump administrations China has historically been a major market for Nvidia. It accounted for 26% of revenue in the fiscal year that ended in January 2022. But export restrictions dragged that figure down to 22% in fiscal 2023, 17% in fiscal 2024 and 13% in fiscal 2025. Meanwhile, CEO Jensen Huang estimates Nvidia's market share in artificial intelligence (AI) chips in China has fallen from 95% to about 50%. The timeline below briefly explains how U.S. policy has evolved over time. On the first-quarter earnings call, Nvidia CFO Colette Kress said, "Losing access to the China AI accelerator market, which we believe will grow to nearly $50 billion, would have a material adverse impact on our business going forward and benefit our foreign competitors worldwide." CEO Jensen Huang has called the export restrictions a failure. He said in May: The question is not whether China will have AI. It already does. The question is whether one of the world's largest AI markets will run on American platforms. Shielding Chinese chipmakers from U.S. competition only strengthens them abroad and weakens America's position. The Trump administration will grant licenses allowing Nvidia to sell H20 GPUs in China On Monday, July 14, Nvidia said it has filed applications to resume selling H20 GPUs in China and has received assurances from the U.S. government that licenses will be granted. The news came days after CEO Jensen Huang met with President Trump, and the company plans to begin delivering compliant AI accelerator chips to China soon. Additionally, the Trump administration revoked the Biden-era AI Diffusion Rule earlier this year, which would have limited Nvidia's ability to sell its most advanced AI chips in dozens of countries that have historically been U.S. allies, including Saudi Arabia, the United Arab Emirates (UAE), Singapore and Israel. The Commerce Department said the AI Diffusion Rule, which was announced during the final days of the Biden administration, would have "stifled American innovation and saddled companies with burdensome new regulatory requirements." Additionally, it would have "undermined U.S. diplomatic relations with dozens of countries by downgrading them to second-tier status." Nvidia has already capitalized on the rescission of the AI Diffusion Rule as more countries lean into sovereign AI — meaning wholly owned data center infrastructure not subject to control by another nation. Earlier this year, the company announced partnerships that will bring its chips and networking equipment to Saudi Arabia and the UAE. Wall Street analysts are likely to increase earnings estimates for Nvidia Ultimately, the Trump administration's decision to permit the sale of H20 GPUs into China, coupled with its rescission of the AI Diffusion Rule, means Nvidia now has a larger total addressable market. In turn, Wall Street analysts are likely to raise earnings estimates, and upward revisions tend to correlate with share-price appreciation. The Wall Street consensus currently says Nvidia's earnings will grow at 41% annually through the fiscal year ending in January 2027. That makes the current valuation of 54 times earnings look tolerable. However, upward revisions to earnings estimates would make the stock even more attractive. Investors interested in adding shares to their portfolios should consider buying Nvidia stock now. Trevor Jennewine has positions in Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY. Should you invest $1,000 in Nvidia right now? Offer from the Motley Fool: Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $680,559!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,005,670!* Now, it's worth noting Stock Advisor's total average return is 1,053% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks »
Business Wire
16 minutes ago
- Business Wire
Securities Fraud Investigation Into Biohaven Ltd. (BHVN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz announces an investigation of Biohaven Ltd. ('Biohaven' or the 'Company') (NYSE: BHVN) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BIOHAVEN LTD. (BHVN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 27, 2023, Biohaven disclosed that the FDA had rejected the New Drug Application ('NDA') for its spinocerebellar ataxia ('SCA') treatment, troriluzole, having refused to even review the application after the Phase 3 SCA Trial had failed to meet its primary endpoint. On this news, Biohaven's stock price fell $5.38, or 22.6%, to close at $18.42 per share on July 27, 2023, thereby injuring investors. Then, on March 3, 2025, Biohaven released its fourth quarter and full year 2024 financial results, disclosing that recent data from a late-stage study of its BHV-7000 treatment for bipolar mania 'did not statistically separate from the comparator on the Young Mania Rating Scale primary outcome measure[.]' On this news, Biohaven's stock price fell $5.12, or 13.8%, to close at $32.06 per share on March 3, 2025. Then, on April 25, 2025, news reports emerged that, according to the European Medicines Agency ('EMA'), Biohaven had withdrawn its Marketing Authorization Application ('MAA') for troriluzole in late March 2025. On this news, Biohaven's stock price fell $3.56, or 15.2%, to close at $19.84 per share on April 25, 2025. Then, on May 14, 2025, Biohaven announced that 'the Division of Neurology 1 within FDA's Office of Neuroscience informed the Company that they are extending the [Prescription Drug User Fee Act ('PDUFA')] date for the troriluzole [NDA] for the treatment of [SCA] by three months to provide time for a full review of Biohaven's recent submissions related to information requests from the FDA,' and that '[t]he Division also informed Biohaven that it is currently planning to hold an advisory committee meeting to discuss the application, but no date has been scheduled.' On this news, Biohaven's stock price fell $3.84, or 19.5%, to close at $15.82 per share on May 15, 2025, thereby injuring investors further. Contact Us To Participate or Learn More: If you purchased Biohaven securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Century City, California 90067 Call us at: 310-914-5007 Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Politico
17 minutes ago
- Politico
Why Some Trump Allies Want to Protect the Fed's Independence
Few things seem to gall President Donald Trump more than Federal Reserve Chair Jerome Powell's disregard for his views on interest rates. The status quo, where Trump allows Powell to serve out his term until next May, feels untenable, with the president venting grievances and chafing at restrictions on his executive power. What happens next to the Fed may hinge on a counterintuitive question: Can temperate voices persuade Trump that the central bank's insulation from immediate political pressures — from him — is actually good for him? Some of Trump's allies have been making that case to me, and likely to him as well. However exasperating Trump finds the Fed's independence, these supporters see political value to the president in having some distance from the central bank. The idea that Trump is persuadable on this point might seem especially far-fetched this week, after he floated the idea of firing Powell to a group of House Republicans, even reportedly showing them a draft letter that would complete the task. Markets dropped on Wednesday as they digested the possibility that Trump might really try to remove the Fed chief, a move he has been actively considering. But he walked it back soon after. It is a cycle we've seen before. (My colleague Megan Messerly and I reported that Treasury Secretary Scott Bessent talked Trump down from a springtime anti-Powell eruption.) And here we are: Trump still has not yet tried to fire Powell. It's legally questionable whether he really could, and the Supreme Court hinted recently that it might shield Powell from such a move. Trump is also aware of the financial instability it would create to attempt to punish the chair so directly for not cutting interest rates. That would suggest, at minimum, that he understands the need for the Fed chair to have credibility with markets. But is that enough to make him pick a person to succeed Powell who has pledged some level of independence? Some of the president's allies are arguing in private that having a Fed chair who is not simply a yes man is a way to help head off the kind of damaging inflation that sank Democrats in 2024. That is, investors and businesses have to believe that the central bank is willing to do what's necessary to avoid inflation, even if that means higher rates. One of the lessons from the 1970s, when President Richard Nixon successfully pressured then-Chair Arthur Burns to keep rates low — and a dramatic lesson from Turkey — is that lowering rates in response to political pressure can lead to higher inflation and force even higher rates down the road. JPMorgan Chase CEO Jamie Dimon made a similar point on Tuesday when I asked him if he was worried about risks that might arise from a less autonomous Fed. 'The independence of the Fed is absolutely critical, and not just for the current Fed chairman, who — I respect Jay Powell — but for the next Fed chairman,' Dimon said to me and other reporters on a call shortly after his bank announced earnings. 'Playing around with the Fed can often have adverse consequences, the absolute opposite of what you might be hoping for.' It's also a theme I've heard on Capitol Hill. 'The independence of the Fed chair may very well come back and help the administration as the economic growth improves with the policies being implemented,' Sen. Mike Rounds (R-S.D.) told me recently. Trump clearly doesn't fully buy into this idea, but it's an open and critical question whether he buys into it at all. At the very least, his administration still feels the need to publicly endorse the Fed's freedom to set policy as it sees fit. 'Everybody at the White House understands the independence of the Fed is super important,' National Economic Council Director Kevin Hassett, himself a top candidate to replace Powell, said on NBC Wednesday evening. When central banks lose their independence, Hassett said, 'it's bad for the economy and bad for markets.' There's also another classic reason for presidents to like Fed independence: It gives them a scapegoat if the economy goes south. The expectation from investors is that anyone Trump picks will be more receptive to his calls for lowering borrowing costs than Powell is, though there is a wide spectrum of ways that could play out in practice. Certainly, regularly communicating with the president seems to be a baseline expectation. The short list for now is Hassett; former Fed board member Kevin Warsh; Bessent, and current Fed board member Chris Waller, people familiar with the deliberations have told me and my colleague Rachael Bade. The two Kevins are seen as the frontrunners, and Trump said this week that he likes Bessent better where he is at Treasury. All four candidates have suggested that rates should be lower. They likely differ in how low and how fast. It's not an unusual view among economists that the Fed should consider moving later this month rather than waiting until September, with signs that the economy might be slowly weakening and inflation only slightly above 2 percent. Even Powell is forecasting that the Fed will cut rates this year, though he's in no rush to do so, citing uncertainty around how tariffs will play out in the economy. But Trump has called for rates to be dramatically lower, and it's unclear whether any of the frontrunners to replace Powell have such large cuts in mind. Hassett didn't dismiss the idea in the NBC interview Wednesday but didn't endorse it either. Trump's preferred rate might be hard to achieve for any Fed chair. Powell is only one of 12 people who vote on monetary policy, and a future central bank leader who is viewed merely as a stooge of the president might have a harder time making an intellectual case to the rest of the committee. This is also a point that people in Trump's circle have brought up to me, and the president himself recently posted on Truth Social that those other Fed officials are 'equally to blame' for rates staying high. But a new Fed chief could — under current economic conditions — easily make the case for smaller, more gradual cuts, with Trump's influence potentially leading rates to go lower than they otherwise would. Julia Coronado, who is president of the Wall Street consulting firm MacroPolicy Perspectives, argued that any Trump pick for the job will be viewed by markets as having less inflation-fighting credibility than prior Fed chairs since Paul Volcker. 'It's too strong to say [the Fed's independence] is the dam that hasn't broke, because it doesn't look good,' she said. But if Trump tries to kill off that independence entirely, he might not love the world he ends up with. The Fed's future will be determined by whether he heeds that warning.
